Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.
Beskrivning
Over the past two decades, spectacular advances have been made in our understanding of the molecular genetics of cancer, leading to the pursuit of identifying genes that, when mutated, result in an increased susceptibility to the disease.
From the reviews:“This well-written and concise book is very timely, given the significant advances in the understanding of molecular genetics of cancer over the past two decades that led to the identification of genes which, when mutated, result in increased susceptibility to disease. … It is written for scientists and clinicians … . This book will be valuable resource for students, scientists, clinical oncologists, and other researchers interested in learning about cancer susceptibility.” (Omer Iqbal, Doody’s Review Service, February, 2011)“Michelle Webb is attempting to give the readers the tools to achieve just that in the oncology field. The book provides up to date protocols and guides aimed at identification of mutations in the known cancer susceptibility genes as well as guides on how to search new ones. … this book provides valuable and relevant information about susceptibility genes analysis and I’m sure it won’t spend too much time just lying on the shelf in any research or clinical lab in this field.” (J. Markus, Neoplasma, February, 2011)“Cancer susceptibility methods and protocols is an up to date book illustrating a collection of molecular protocols intended to represent the basic and advanced molecular techniques which used to identify and screen for cancer susceptibility genes. … This book deserves great praise for the readable presentation of this complex field. … a valuable authoritative and accessible resource for the current molecular methods used to explore and screen for cancer genes. Both cancer biologists and very specialized clinicians … will find this book a good reference.” (Abeer Alsaegh and Diana M. Eccles, Human Genetics, Vol. 131, 2012)
Innehållsförteckning
Identifying Cancer Susceptibility Genes.- The Identification of Colon Cancer Susceptibility Genes by Using Genome-Wide Scans.- Prioritizing Candidate Genetic Modifiers of BRCA1 and BRCA2 Using a Combinatorial Analysis of Global Expression and Polymorphism Association Studies of Breast Cancer.- Microarray-Based Comparative Genomic Hybridization (Array-CGH) as a Useful Tool for Identifying Genes Involved in Glioblastoma (GB).- Multiplex Amplifiable Probe Hybridization (MAPH) Methodology as an Alternative to Comparative Genomic Hybridization (CGH).- Utilizing Saccharomyces Cerevisiae to Identify Aneuploidy and Cancer Susceptibility Genes.- Computational Identification of Cancer Susceptibility Loci.- Digital Candidate Gene Approach (DigiCGA) for Identification of Cancer Genes.- Screening Cancer Susceptibility Genes.- The Use of Denaturing High Performance Liquid Chromatography (DHPLC) for Mutation Scanning of Hereditary Cancer Genes.- Enhanced Mismatch Mutation Analysis: Simultaneous Detection of Point Mutations and Large Scale Rearrangements by Capillary Electrophoresis, Application to BRCA1 and BRCA2.- Economical Protocol for Combined Single-Strand Conformation Polymorphism and Heteroduplex Analysis on a Standard Capillary Electrophoresis Apparatus.- Mutational Screening of hMLH1 and hMSH2 that Confer Inherited Colorectal Cancer Susceptibility Using Denature Gradient Gel Electrophoresis (DGGE).- s-RT-MELT: A Novel Technology for Mutation Screening.- Zoom-In Array Comparative Genomic Hybridization (aCGH) to Detect Germline Rearrangements in Cancer Susceptibility Genes.- Development of a Scoring System to Screen for BRCA1/2 Mutations.- Use of Splicing Reporter Minigene Assay to Evaluate the Effect on Splicing of Unclassified Genetic Variants.- Functional Analysis of Human BRCA2 Variants Using a Mouse Embryonic Stem Cell-Based Assay.- Developing Functional Assays for BRCA1 Unclassified Variants.
